Runsheng Ma

424 total citations
20 papers, 300 citations indexed

About

Runsheng Ma is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Runsheng Ma has authored 20 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Runsheng Ma's work include RNA modifications and cancer (4 papers), Thyroid Cancer Diagnosis and Treatment (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Runsheng Ma is often cited by papers focused on RNA modifications and cancer (4 papers), Thyroid Cancer Diagnosis and Treatment (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Runsheng Ma collaborates with scholars based in China and Australia. Runsheng Ma's co-authors include Hongqiang Li, Detao Yin, Mengyuan Lei, Kun Yu, Jing Xie, Zhen Liu, Yongfei Wang, Lele Zhang, Zunshui Cheng and Rui Bu and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Neurocomputing and BMC Cancer.

In The Last Decade

Runsheng Ma

20 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Runsheng Ma China 11 186 96 81 49 33 20 300
Stella‐Rita Ibeawuchi United States 10 227 1.2× 41 0.4× 51 0.6× 31 0.6× 45 1.4× 16 401
Xun Chi United States 8 182 1.0× 110 1.1× 171 2.1× 14 0.3× 97 2.9× 11 527
Na Lü China 8 98 0.5× 25 0.3× 14 0.2× 31 0.6× 41 1.2× 26 305
Emmanuelle Ruiz United States 10 127 0.7× 56 0.6× 84 1.0× 51 1.0× 49 1.5× 22 272
Hanqing Guo China 9 174 0.9× 96 1.0× 25 0.3× 47 1.0× 27 0.8× 17 320
Ling Zhou China 10 96 0.5× 35 0.4× 31 0.4× 56 1.1× 25 0.8× 36 299
Wenzhuo Yang China 11 152 0.8× 123 1.3× 20 0.2× 19 0.4× 13 0.4× 22 383
Daniela Santos‐Silva Portugal 9 93 0.5× 48 0.5× 68 0.8× 79 1.6× 15 0.5× 11 327
Lili Zhuo China 11 176 0.9× 49 0.5× 20 0.2× 34 0.7× 37 1.1× 18 312
Feng Ding China 11 231 1.2× 185 1.9× 57 0.7× 14 0.3× 15 0.5× 17 379

Countries citing papers authored by Runsheng Ma

Since Specialization
Citations

This map shows the geographic impact of Runsheng Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Runsheng Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Runsheng Ma more than expected).

Fields of papers citing papers by Runsheng Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Runsheng Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Runsheng Ma. The network helps show where Runsheng Ma may publish in the future.

Co-authorship network of co-authors of Runsheng Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Runsheng Ma. A scholar is included among the top collaborators of Runsheng Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Runsheng Ma. Runsheng Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Longlong, et al.. (2025). Semaglutide Reprograms Macrophages via the GLP-1R/PPARG/ACSL1 Pathway to Suppress Papillary Thyroid Carcinoma Growth. The Journal of Clinical Endocrinology & Metabolism. 110(10). 2777–2789. 5 indexed citations
3.
Wang, Ziyang, et al.. (2024). Sciellin promotes the development and progression of thyroid cancer through the JAK2/STAT3 signaling pathway. Molecular Carcinogenesis. 63(4). 701–713. 3 indexed citations
4.
Guo, Haohao, et al.. (2023). Ibuprofen inhibits anaplastic thyroid cells in vivo and in vitro by triggering NLRP3-ASC-GSDMD-dependent pyroptosis. Inflammopharmacology. 32(1). 733–745. 3 indexed citations
5.
Guo, Haohao, Ziyang Wang, Runsheng Ma, et al.. (2023). A novel pharmacological mechanism of anti-cancer drugs that induce pyroptosis. Inflammopharmacology. 31(2). 745–754. 22 indexed citations
6.
Liu, Zhen, et al.. (2022). Evaluation of Autofluorescence in Identifying Parathyroid Glands by Measuring Parathyroid Hormone in Fine-Needle Biopsy Washings. Frontiers in Endocrinology. 12. 819503–819503. 2 indexed citations
7.
8.
Zhang, Xiaozhou, Xiaojian Zhang, Qian Jia, et al.. (2022). LncRNA CALML3-AS1 suppresses papillary thyroid cancer progression via sponging miR-20a-5p/RBM38 axis. BMC Cancer. 22(1). 344–344. 8 indexed citations
9.
Ma, Runsheng, et al.. (2021). SQSTM1/p62 Promotes Cell Growth and Triggers Autophagy in Papillary Thyroid Cancer by Regulating the AKT/AMPK/mTOR Signaling Pathway. Frontiers in Oncology. 11. 638701–638701. 21 indexed citations
10.
Ma, Runsheng, et al.. (2021). Increased Expression of hsa_circ_0002111 and Its Clinical Significance in Papillary Thyroid Cancer. Frontiers in Oncology. 11. 644011–644011. 16 indexed citations
11.
Li, Ang, Tiantian Li, Xinxin Gao, et al.. (2021). Gut Microbiome Alterations in Patients With Thyroid Nodules. Frontiers in Cellular and Infection Microbiology. 11. 643968–643968. 29 indexed citations
12.
Ma, Runsheng, et al.. (2021). Cep63 knockout inhibits the malignant phenotypes of papillary thyroid cancer cell line TPC‑1. Oncology Reports. 46(3). 2 indexed citations
13.
Ma, Runsheng, et al.. (2021). The Antitumour Effect of Prunella vulgaris Extract on Thyroid Cancer Cells In Vitro and In Vivo. Evidence-based Complementary and Alternative Medicine. 2021. 1–12. 13 indexed citations
14.
Ma, Runsheng, et al.. (2021). Upregulated SLC27A2/FATP2 in differentiated thyroid carcinoma promotes tumor proliferation and migration. Journal of Clinical Laboratory Analysis. 36(1). e24148–e24148. 19 indexed citations
15.
Ma, Runsheng, et al.. (2020). The Role of Exosomes in Thyroid Cancer and Their Potential Clinical Application. Frontiers in Oncology. 10. 596132–596132. 18 indexed citations
16.
Li, Hongqiang, et al.. (2019). Upregulation of the long non-coding RNA FOXD2-AS1 is correlated with tumor progression and metastasis in papillary thyroid cancer.. PubMed. 11(9). 5457–5471. 21 indexed citations
17.
Zhang, Lele, et al.. (2019). Generation and identification of a thyroid cancer cell line with stable expression of CCDC67 and luciferase reporter genes. Oncology Letters. 18(5). 4495–4502. 1 indexed citations
18.
Yin, Detao, Kun Yu, Jing Xie, et al.. (2018). The association between thyroid cancer and insulin resistance, metabolic syndrome and its components: A systematic review and meta-analysis. International Journal of Surgery. 57. 66–75. 70 indexed citations
19.
Wang, Tianshun, Zunshui Cheng, Rui Bu, & Runsheng Ma. (2018). Stability and Hopf bifurcation analysis of a simplified six-neuron tridiagonal two-layer neural network model with delays. Neurocomputing. 332. 203–214. 20 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stella‐Rita Ibeawuchi Breakdown of academic impact, for papers by Xun Chi Breakdown of academic impact, for papers by Na Lü Breakdown of academic impact, for papers by Emmanuelle Ruiz Breakdown of academic impact, for papers by Hanqing Guo Breakdown of academic impact, for papers by Ling Zhou Breakdown of academic impact, for papers by Wenzhuo Yang Breakdown of academic impact, for papers by Daniela Santos‐Silva Breakdown of academic impact, for papers by Lili Zhuo Breakdown of academic impact, for papers by Feng Ding
Rankless by CCL
2026